The Endocrine Testing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The endocrine testing market size has been experiencing robust growth in the past years. In 2024, it was valued at $2.55 billion and is projected to reach $2.8 billion in 2025. The compound annual growth rate (CAGR) was recorded at 9.8%.
The Endocrine Testing market is predicted to reach a value of $4.01 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.5%.
Download Your Free Sample of the 2025 Endocrine Testing Market Report and Uncover Key Trends Now!The drivers in the endocrine testing market are:
• Discovery of new hormones and endocrine pathways
• Standardization of diagnostic tests
• Public health initiatives
• Increased patient advocacy and empowerment
The endocrine testing market covered in this report is segmented –
1) By Test Type: Estradiol (E
2) Test, Follicle Stimulating Hormone (FSH) Test, Human Chorionic Gonadotropin (hCG) Hormone Test, Luteinizing Hormone (LH) Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Progesterone Test, Testosterone Test, Thyroid Stimulating Hormone (TSH) Test, Prolactin Test, Other Types
2) By Technology: Tandem Mass Spectrometry, Immunoassay, Monoclonal And Polyclonal Antibody Technologies, Sensor Technology, Clinical Chemistry, Other Technologies
3) By End-User: Hospitals, Clinical Laboratories, Diagnostic Centers, Other End-Users
The trends in the endocrine testing market are:
• Advancements in biomarker detection are emerging as a trend in endocrine testing.
• Integration of omics technologies is shaping the future of the endocrine testing market.
• The use of artificial intelligence and machine learning is a significant upcoming trend.
• Quality assurance, standardization, and collaborative research and translational medicine are key trends shaping the sector.
The major players in the endocrine testing market are:
• Thermo Fisher Scientific Inc.
North America was the largest region in the endocrine testing market in 2023